Ovarian age and ovarian reserve
Your ovaries have an age of their own, and it does not always match the age in your passport. Ovarian age helps a woman understand her ovarian reserve, the course of her reproductive years and the likely timing of menopause. In this article, we explain the topic in clear language for gynaecologists and for every woman.
Laitech Knowledge Centre · 2026-11-14 · 16 min read
There is one organ in a woman’s body whose “clock” runs differently from all the others. While still in the womb, the ovaries form the reserve of eggs that a woman will draw on throughout her reproductive life, and this reserve declines naturally over the years. The rate of that decline, however, differs from woman to woman: two women of the same age can have ovarian reserves that differ several-fold.
That is why modern gynaecology does not look at a woman’s age by the calendar alone. Ovarian age shows which age a woman’s ovarian reserve corresponds to, helping her know her body better and plan her future with confidence. In this article, we explain in detail what ovarian age is, why it matters, how it is calculated and what we include in the iMedical ovarian age report.
What is ovarian age?
A baby girl is born with roughly one to two million immature eggs in her ovaries. By adolescence this number has fallen to a few hundred thousand, and in each menstrual cycle a group of follicles begins to develop, of which usually only one matures. No new eggs are formed: the reserve can only decrease. As it approaches exhaustion, menstrual cycles change and, eventually, menopause begins.
Ovarian age shows which age group a woman’s ovarian reserve matches on average. For example, if a 34-year-old woman has an ovarian age of 38, her ovarian reserve corresponds to that of an average 38-year-old. Ovarian age can also be lower than chronological age, in which case the reserve is above the average for her peers.
Ovarian age is not a diagnosis; it is a clear unit of measure for understanding a woman’s reproductive health. The number speaks a language everyone understands: it answers the question “how old are my ovaries?”. For the gynaecologist, more precise clinical information stands behind it: the percentile for the age group, the reference range and the consistency with other markers.
Quantity and quality: Ovarian reserve reflects the number of eggs remaining in the ovaries. The quality of the eggs, on the other hand, is determined mainly by a woman’s chronological age. That is why ovarian age is always assessed together with chronological age.
Why ovarian age matters for women
Today women make decisions about education, career and family later in life than previous generations did. In this context, knowing your reproductive timeline means having choices. Ovarian age brings clarity to the following questions:
- Family planning. For a woman whose ovarian reserve is low for her age and who is planning a pregnancy, it is important to see a reproductive specialist without delay. A woman with a normal reserve can plan with greater peace of mind.
- Egg and embryo freezing. If a decline in reserve is expected because of ovarian surgery, endometriosis or medical treatment, assessing the reserve in good time makes it possible to make the right decision about fertility preservation.
- The timing of menopause. Ovarian reserve is linked to the likely timing of menopause. Knowing the expected age of menopause makes it possible to build a prevention plan for bone, cardiovascular and overall health in advance.
- The cause of menstrual irregularities. A very high AMH may be associated with polycystic ovarian morphology, and a very low AMH with ovarian insufficiency. In both cases the result is a valuable signal for the gynaecologist’s assessment.
- Preparing for assisted reproduction. In in vitro fertilisation (IVF), ovarian reserve is used to assess how the ovaries are likely to respond to stimulation.
The value of ovarian age goes beyond pregnancy planning. Menopause before the age of 45, and especially ovarian insufficiency before 40, is associated with reduced bone density and an increased risk of cardiovascular disease. Seeing these risks in advance gives a woman the opportunity to take protective steps together with her doctor in good time. In other words, ovarian age is an indicator that touches a woman’s entire quality of life.
A woman who knows her reproductive timeline can plan her family’s future with greater confidence.
- 18–50: the age range of women for whom it is calculated
- 10: sections in the detailed report
- 9: report languages
AMH: the key marker of ovarian reserve
The most reliable laboratory marker for measuring ovarian reserve is anti-Müllerian hormone (AMH). AMH is produced by the small, developing follicles in the ovaries. The more follicles there are, the higher the circulating AMH level. AMH is therefore an indirect but highly informative marker of the reserve remaining in the ovaries.
The main advantage of AMH is that it stays relatively stable throughout the menstrual cycle, so the test can be taken on any day of the cycle. Unlike other hormones, AMH begins to reflect a decline in ovarian reserve years in advance. Even so, several important points need to be taken into account to interpret AMH correctly:
- The laboratory analyser. Different analysers can measure AMH with different values. The result should therefore be compared with the age table that matches the analyser used, and repeat measurements should be taken at the same laboratory on the same analyser.
- Hormonal contraception. Combined hormonal contraceptives make AMH appear roughly 20–30% lower. This is not a decline in reserve but a temporary change in the measurement. The report takes the type of contraception into account and, where needed, recommends a repeat measurement 2–3 months after stopping it.
- Endometriosis and ovarian surgery. An endometrioma or the removal of an ovarian cyst can lower AMH. This information is noted separately in the report’s section for the doctor.
- Smoking. Smoking accelerates the decline in ovarian reserve and brings menopause forward by roughly 1–2 years.
An important clarification: AMH does not predict the chance of conceiving naturally. Scientific research shows that among women aged 30–44 with a low reserve, the likelihood of natural pregnancy within 6 and 12 months is the same as among women with a normal reserve. AMH reflects the number of eggs and is not a reason to stop contraception.
When AMH, FSH, LH and oestradiol are measured in the same sample, a more complete picture of ovarian reserve emerges.
Markers that complement AMH
Ovarian age is calculated from AMH, but the report also compares the reserve with other markers. FSH and oestradiol measured on days 2–4 of the cycle, and the antral follicle count (AFC) assessed by transvaginal ultrasound on days 2–5, either confirm the AMH result or offer a different perspective on it. TSH and prolactin help to rule out other causes of menstrual irregularities. The report states plainly whether these markers agree with one another: “the markers are consistent with a diminished reserve”, “the markers do not indicate a diminished reserve” or “the markers are not consistent with one another”.
How we calculate ovarian age
The iMedical ovarian age report assesses laboratory results together with the information a woman provides about herself. The calculation goes through several consecutive stages:
1. AMH is compared with an age-based reference table
The woman’s AMH value is compared with an international reference table, divided into age groups, that matches the analyser used. The age at which this value equals the average for women is determined: this is her ovarian age.
2. The reserve is assessed within her own age group
Based on the percentile AMH falls into within the woman’s own five-year age group, it is assigned to one of five categories: below the reference range, near the lower limit, normal (below the median), normal (above the median) and above the reference range.
3. Contraception and other factors are taken into account
Because hormonal contraception makes AMH appear lower, the result is adjusted for the type of contraception. Information such as endometriosis, ovarian surgery, smoking, body mass index, number of births and the mother’s age at menopause is built into the interpretation.
4. The likely timing of menopause is calculated
Based on age, AMH and personal factors, the expected age of menopause and the range within which it will fall with 80% probability are determined. At the same time, the probabilities of ovarian insufficiency before 40, menopause before 45 and menopause in the coming years are calculated.
5. The results become a personal action plan
In plain language, the report sets out which doctor the woman should see and how soon, which tests she should repeat and what she should pay attention to in order to protect her reserve.
One principle underpins the calculation: each factor is counted only once. For example, if the effect of smoking on ovarian reserve is already reflected in AMH, it is not counted a second time in the menopause forecast. This approach prevents the result from being overstated and shows the woman the real picture.
In some cases ovarian age is not expressed as a single number: for example, when AMH corresponds to the oldest group in the age table or is lower still. Ovarian age is not calculated during pregnancy, after menopause, after removal of both ovaries or in women over 50, because in these situations AMH does not accurately reflect ovarian reserve. If AMH has not been measured, a separate sheet is prepared instead of the report, showing the woman which tests she needs to take.
A method built on international gynaecological standards
The ovarian age report is built on the internationally accepted scientific foundation of gynaecology and reproductive medicine. The measurement and interpretation of ovarian reserve follow the recommendations of the American Society for Reproductive Medicine (ASRM), the criteria for diminished reserve and ovarian insufficiency follow the clinical guidelines of the European Society of Human Reproduction and Embryology (ESHRE), and the reproductive stages are based on the international STRAW+10 classification. Recommendations on menopause are aligned with NICE clinical guidelines and the findings of large international cohort studies.
Every recommendation in the report covers evidence-based medical approaches only. Supplements and procedures marketed as able to “rejuvenate” ovarian age but lacking scientific confirmation are not recommended in the report. Supplements are advised only when a deficiency has been confirmed by laboratory tests and on a doctor’s recommendation.
Scientific consultant to the project: Dr. Natiq Məhərrəmov, PhD
Surgeon obstetrician-gynaecologist, PhD in Medicine
The ovarian age report was developed with the scientific guidance of Dr. Natiq Məhərrəmov, PhD. Dr. Məhərrəmov is a surgeon obstetrician-gynaecologist with more than 16 years of clinical experience. He specialises in laparoscopic surgery, infertility treatment and perinatal medicine, is the author of more than 30 international scientific publications and conducts research at the Department of Obstetrics and Gynaecology of the Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev. His clinical experience has shaped the report to be clear and practical for women and gynaecologists alike.
What the ovarian age report includes
The iMedical ovarian age report is designed to be easy to read on a phone screen and is made up of consecutive sections. The first page gives a woman the most important answers at a glance, while the following sections explain each result in detail. Below you can see a sample of the report’s first page.
Ovarian age: Age-based assessment of ovarian reserve
Sample ovarian age report. The values are illustrative.
Your ovarian age is 4.6 years higher than your chronological age. Expected age at menopause: 48.1. Menopause will occur between the ages of 44.3 and 51.6 with 80% probability.
- Chronological age: 34
- Ovarian age: 38.6
- Expected menopause: 48.1 (44.3-51.6)
- AMH · age group 30–34: 1.6 ng/mL · Normal for age, below the median
- Pace of ageing: In line with age
- Probability of ovarian insufficiency before 40: 2%
- Probability of menopause before 45: 18%
- Probability of menopause in the next 5 years: 1%
- Within 6 months: See a reproductive gynaecologist: you are planning a pregnancy and your ovarian age is higher than your chronological age.
- Days 2–5 of the cycle: Have your antral follicle count measured by transvaginal ultrasound.
- After 12 months: Repeat the AMH measurement at the same laboratory on the same analyser.
The sections of the report answer the following questions in turn:
- Age line. Chronological age, ovarian age, the expected age at menopause and its probability range are shown on a single line, so a woman can see where she stands at a glance.
- Reproductive stage. Explains which stage of the reproductive years the woman is currently in and what to pay attention to in the next stage.
- What should you do? A personal action plan: which specialist to see and how soon, pregnancy planning, protecting the reserve and repeat tests.
- Ovarian age. A chart of AMH by age, where the woman’s value sits among her peers, how quickly her ovarian reserve is declining and how it agrees with other markers.
- Timing of menopause. The probabilities of ovarian insufficiency before 40, menopause before 45 and menopause in the coming years, plus the information needed to refine the forecast.
- Women’s health background. General health markers such as vitamin D, iron stores, thyroid, carbohydrate and lipid metabolism, liver and kidneys.
- Recommendations. Nutrition, physical activity, body weight, sleep, stress, smoking and alcohol, bone and heart protection: only those relevant to the woman’s results.
- Tests needed. Which tests are needed for a complete calculation, and on which day of the cycle they should be taken.
- What the result means. Short, clear explanations of what AMH does and does not show.
- For the doctor. A clinical section addressed to the gynaecologist: the patient’s self-reported history, percentiles, analyser information and next clinical steps.
The age line and the pace of ageing
The age line on the first page of the report presents complex information in its simplest form. On a single line it places the woman’s chronological age, her ovarian age and the gap between them, the expected age at menopause, the range within which it will fall with 80% probability, and the average age at menopause in the population. Beneath it, the result is summed up in one sentence: “Your ovarian age is 4.6 years higher than your chronological age” or “Your ovarian age is in line with your chronological age”.
The pace of ageing shows whether ovarian reserve is declining at the rate expected for the woman’s age: “faster than expected”, “in line with age” or “slower than expected”. If the woman has a previous AMH result, the report also calculates how many years her ovarian age has advanced per calendar year between the two measurements. This allows the woman and her doctor to follow the dynamics of her reserve over the years.
The timing of menopause: a probability range, not an exact date
Menopause is a natural stage in a woman’s life, but its timing is highly important for a personal health plan. The report presents the expected age of menopause not as a single date but as a probability range: “Menopause will occur between the ages of 44.3 and 51.6 with 80% probability.” This approach is scientifically honest and allows a woman to understand her situation realistically.
The width of the forecast range depends on how complete the information provided is. If AMH has been measured, the forecast narrows considerably; if not, it is based on age and lifestyle and the range is wide. The report shows separately how much each missing piece of information would narrow the forecast: for example, “AMH: the range would narrow from 9 years to 5”. This makes it clear to a woman which test would tell her the most.
The menopause section shows three probabilities: ovarian insufficiency before 40, menopause before 45 and menopause in the coming years. When the probability of early menopause is high, the report also lists the steps to discuss with a doctor to protect bone and heart health. For example, for menopause before the age of 45, it is recommended to discuss hormone therapy with a doctor, at least until the age of natural menopause.
Women’s health background
The health of the ovaries is inseparable from the health of the whole body. The “Women’s health background” section of the report assesses a woman’s general health markers across ten groups: vitamin D, iron stores and haemoglobin, vitamin B12 and folic acid, an inflammation marker, liver, kidneys, carbohydrate metabolism, thyroid, lipids and calcium.
The result of this section is expressed as one of four states: “good”, “needs attention”, “poor” or, if there are not enough tests, “insufficient tests”. As ovarian age advances and menopause approaches, this background becomes more important: a healthy background helps a woman enter menopause stronger and healthier. The section also shows how much these general markers affect biological age, and links to iMedical’s biological age report.
A dedicated section for the gynaecologist
The first part of the report is written in plain language for the woman. The final section, by contrast, is addressed directly to the gynaecologist and is written in clinical terms. Here the doctor sees all the information needed for the consultation in one place:
- Patient’s self-reported history: menstrual cycle characteristics, the cycle day on which the sample was taken, births and pregnancy losses, hormonal medication, smoking, the mother’s age at menopause, ovarian surgery, chemotherapy or pelvic radiotherapy, diagnoses and imaging findings.
- Report findings: AMH value, percentile for the age group, the analyser and reference table used, and the concordance of AMH, AFC, FSH and oestradiol.
- Clinical context: the effect of endometrioma and cystectomy on AMH, and the exclusion of secondary causes (hyperprolactinaemia, thyroid disorders, androgen excess).
- Next clinical steps: AFC by transvaginal ultrasound, repeat AMH on the same platform, consultation with a reproductive specialist, fertility preservation counselling and further investigations when ovarian insufficiency is suspected.
This structure saves the gynaecologist time: the history has already been organised, the results have been compared with international criteria, and the woman arrives at the consultation already understanding her result. The report is a tool that complements the doctor’s clinical decision and gives it a firmer foundation: the final assessment always rests with the gynaecologist.
A good report builds a bridge between doctor and patient: the woman understands her result, and the doctor sees all the information needed for a decision on a single page.
How to prepare for the tests
For an accurate assessment of ovarian age, the iMedical Test Plan offers women a dedicated test panel. The panel is designed for women aged 18 to 50:
- AMH (essential): can be taken on any day of the cycle. Ovarian age is calculated from this test.
- FSH, LH and oestradiol: on days 2–4 of the cycle, in the same sample. These confirm the AMH result.
- TSH and prolactin: rule out other causes of menstrual irregularities.
- Transvaginal ultrasound, antral follicle count: on days 2–5 of the cycle. Assesses ovarian reserve directly through imaging.
Alongside the tests, a woman is asked to complete a short questionnaire: the regularity and length of her menstrual cycle, pregnancy plans, hormonal medication (including contraception), smoking, ovarian surgery, chemotherapy or radiotherapy, her mother’s age at menopause, height and weight. This information personalises the interpretation of the result. For women taking hormonal contraception, FSH, LH and oestradiol do not reflect ovarian reserve, so they are removed from the panel and a separate note explains why.
Who is the ovarian age report for?
The report is useful for all women aged 18 to 50 who still have menstrual cycles. Knowing your ovarian age is especially valuable for:
- Women planning a pregnancy in the future who want to know their reproductive timeline.
- Women planning a pregnancy after the age of 35.
- Women with irregular menstrual cycles or a change in cycle length.
- Women diagnosed with endometriosis or who have had ovarian surgery.
- Women with a family history of early menopause.
- Women who are due to have, or have had, chemotherapy or pelvic radiotherapy.
- Women considering egg freezing or IVF.
- Women who want to plan ahead for the menopausal transition.
For gynaecologists, reproductive specialists and women’s health clinics, the report is a tool that structures the conversation with the patient, translates the result into language the woman understands and brings the clinical information together in one place.
How to get the ovarian age report
The ovarian age report is available in two ways:
- Through the Laylay mobile app. Women upload their AMH and other test results from any laboratory to the Laylay app, complete a short questionnaire and receive the report on their phone. Laylay is the app we have created for women’s health, pregnancy and baby care: laylay.app.
- Through clinics and hospitals. Gynaecology clinics, reproductive medicine centres, hospitals and laboratories can offer the report to their patients through a corporate partnership with Laitech. The report is integrated into the organisation’s information system and is available in 9 languages.
With the Laylay app, you can upload your test results and receive your ovarian age report on your phone.
In a corporate partnership, the report is adapted to the organisation’s workflow: as soon as a laboratory result is ready, the report is generated automatically and delivered both to the woman and to her gynaecologist. For a clinic, this is an opportunity to expand its women’s health services, build long-term relationships with patients and offer a modern, personalised service. Used together with CareNext, ovarian age and the timing of menopause help to anticipate a woman’s future health needs and offer her the right service at the right time.
Healthy women, a healthy future
At Laitech, we place human health above all else. One idea guided us as we developed the ovarian age report: healthy women, a healthy future. A woman’s health is the health of her family, of society and of generations to come. A woman who knows her reproductive timeline, understands her result and makes timely decisions together with her doctor builds a more secure future for herself and her family.
Healthy women, a healthy future: the continuation of humankind begins with women’s health.
Creating technologies that make scientific knowledge understandable for every woman is part of our mission. The ovarian age report brings together the international scientific foundation of gynaecology, the clinical expertise of an experienced surgeon obstetrician-gynaecologist and Laitech’s smart technologies. Our goal is simple: every woman should have clear information about her own health, and that information should improve her quality of life.
Frequently asked questions
What is ovarian age?
Ovarian age shows which age group a woman’s ovarian reserve matches on average. It is calculated from an AMH test using age tables that match the analyser, and it is always assessed together with chronological age.
On which day of the cycle should the AMH test be taken?
Because AMH stays relatively stable throughout the cycle, the test can be taken on any day. FSH, LH and oestradiol, however, should be measured on days 2–4 of the cycle, and the ultrasound for the antral follicle count on days 2–5.
If my AMH is low, can I still conceive naturally?
Yes. AMH reflects the number of eggs; it does not predict the chance of natural pregnancy. Research shows that among women aged 30–44 with a low reserve, the likelihood of pregnancy within 6 and 12 months is the same as among women with a normal reserve. If a pregnancy is planned, a woman with a low reserve is advised to see a reproductive gynaecologist without delay.
Does hormonal contraception affect the result?
Yes. Combined hormonal contraceptives make AMH appear roughly 20–30% lower, but the ovarian reserve itself does not decline. The report takes the type of contraception into account and, where needed, recommends repeating the AMH measurement 2–3 months after stopping contraception.
Can ovarian age be reversed?
It is not possible to increase ovarian reserve, that is, the number of follicles. However, avoiding factors that speed up its decline, for example by quitting smoking, maintaining a healthy body weight and correcting deficiencies in good time, helps to protect the reserve.
Can the timing of menopause be predicted precisely?
The report does not give an exact date for menopause; it shows the expected age and the range within which it will fall with 80% probability. When AMH has been measured and the questionnaire is fully completed, the range narrows and the forecast becomes more personal.
Who can get the ovarian age report?
Women aged 18 to 50 who still have menstrual cycles can get the report through the Laylay mobile app. Clinics, hospitals and laboratories can offer the report to their patients through a corporate partnership with Laitech.
How does the report help the gynaecologist?
The report has a dedicated “For the doctor” section that brings together, in one place, the patient’s history in a structured form, the AMH percentile for the age group, analyser information, the concordance of markers and the next clinical steps. This makes the consultation more productive and complements the doctor’s clinical decision.
Let’s strengthen women’s health together
If you would like to offer the ovarian age report to the patients of your clinic, hospital or laboratory, get in touch with us. Together, we will build a partnership model tailored to your organisation’s needs.